UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trastuzumab deruxtecan for breast cancer: do patients experience a comprehensive benefit?

Annals of oncology, 2023-07, Vol.34 (7), p.567-568

2023

Volltextzugriff (PDF)

Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016

Annals of oncology, 2018-12, Vol.29 (12), p.2288-2295

2018

Volltextzugriff (PDF)

Reply to the Letter to the Editor “Importance of pain management in cancer patients and survivors” by K. Bhatt et al

Annals of oncology, 2024-05, Vol.35 (5), p.475-476

Di Maio, M.

2024

Volltextzugriff (PDF)

The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline

Annals of oncology, 2022-09, Vol.33 (9), p.878-892

2022

Volltextzugriff (PDF)

A randomised clinical trial of two docetaxel regimens (weekly 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study

British journal of cancer, 2004-12, Vol.91 (12), p.1996-2004

2004

Volltextzugriff (PDF)

Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer

British journal of cancer, 2004-06, Vol.90 (12), p.2288-2296

2004

Volltextzugriff (PDF)

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy

European journal of cancer (1990), 2021-05, Vol.149, p.153-164

2021

Volltextzugriff (PDF)

The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy

Annals of oncology, 2016-12, Vol.27 (12), p.2224-2229

2016

Volltextzugriff (PDF)

Bevacizumab in non small cell lung cancer: development, current status and issues

Current medicinal chemistry, 2012-03, Vol.19 (7), p.961-971

2012

Volltextzugriff (PDF)

Lessons from clinical trials on quality-of-life assessment in ovarian cancer trials

Annals of oncology, 2016-06, Vol.27 (6), p.961-962

2016

Volltextzugriff (PDF)

Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment

Gynecologic oncology reports, 2019-05, Vol.28, p.44-46

2019

Volltextzugriff (PDF)

Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case–control study

Annals of oncology, 2017-12, Vol.28 (12), p.3009-3014

2017

Volltextzugriff (PDF)

Reply to the letter to the editor ‘On the underreporting of health-related quality of life and regulatory approval’ by Bhamidipati et al

Annals of oncology, 2019-04, Vol.30 (4), p.658-659

2019

Volltextzugriff (PDF)

The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations

Critical reviews in oncology/hematology, 2016-08, Vol.104, p.9-20

2016

Volltextzugriff (PDF)

A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group

British journal of cancer, 2007-06, Vol.96 (11), p.1639-1643

2007

Volltextzugriff (PDF)

Methodology of clinical trials with new molecular-targeted agents: where do we stand?

Annals of oncology, 2006-06, Vol.17 (suppl-7), p.vii128-vii131

2006

Volltextzugriff (PDF)

Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial

Annals of oncology, 2015-04, Vol.26 (4), p.675-682

2015

Volltextzugriff (PDF)

Chemotherapy with immune-checkpoint inhibitors in first-line treatment metastatic NSCLC patients: Systematic review and literature-based meta-analysis

Annals of oncology, 2019-04, Vol.30, p.ii57-ii57

2019

Volltextzugriff (PDF)

QoL is a cool tool

Annals of oncology, 2017-08, Vol.28 (8), p.2032-2033

2017

Volltextzugriff (PDF)

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence

Lung cancer (Amsterdam, Netherlands), 2011-03, Vol.71 (3), p.249-257

2011

Volltextzugriff (PDF)

Tivantinib added to erlotinib in nonsmall-cell lung cancer: the primary end point was not MET

Annals of oncology, 2015-10, Vol.26 (10), p.2007-2009

2015

Volltextzugriff (PDF)

Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature

Gynecologic oncology, 2021-07, Vol.162 (1), p.80-87

2021

Volltextzugriff (PDF)

Progression-free survival as primary end point in advanced non-small-cell lung cancer: does the size matter?

Annals of oncology, 2008-02, Vol.19 (2), p.402-403

2008

Volltextzugriff (PDF)

Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial

British journal of cancer, 2006-05, Vol.94 (9), p.1233-1236

2006

Volltextzugriff (PDF)

1 – 25 von 1.224

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.070)
Mit Volltextzugriff
(1.027)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(622)
Life Sciences & Biomedicine
(445)
Humans
(362)
Female
(202)
Male
(176)
Technology
(164)
Oncology
(140)
Biological And Medical Sciences
(133)
Adult
(117)
Medical Sciences
(115)
Middle Aged
(109)
Physical Sciences
(103)
Aged
(91)
Exact Sciences And Technology
(84)
Applied Sciences
(76)
Neurosciences & Neurology
(70)
Computer Science
(63)
Neurosciences
(61)
Computer Science, Theory & Methods
(57)
Computer Science, Artificial Intelligence
(55)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Trastuzumab deruxtecan for breast cancer: do patients experience a comprehensive benefit?

Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016

Reply to the Letter to the Editor “Importance of pain management in cancer patients and survivors” by K. Bhatt et al

The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline

A randomised clinical trial of two docetaxel regimens (weekly 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study

Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy

The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy

Bevacizumab in non small cell lung cancer: development, current status and issues

Lessons from clinical trials on quality-of-life assessment in ovarian cancer trials

Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment

Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case–control study

Reply to the letter to the editor ‘On the underreporting of health-related quality of life and regulatory approval’ by Bhamidipati et al

The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations

A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group

Methodology of clinical trials with new molecular-targeted agents: where do we stand?

Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial

Chemotherapy with immune-checkpoint inhibitors in first-line treatment metastatic NSCLC patients: Systematic review and literature-based meta-analysis

QoL is a cool tool

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence

Tivantinib added to erlotinib in nonsmall-cell lung cancer: the primary end point was not MET

Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature

Progression-free survival as primary end point in advanced non-small-cell lung cancer: does the size matter?

Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial

Suchergebnisse filtern